The Sub-Sero Study

Conditions:   Schizophrenia;   Psychosis Intervention:   Drug: Pimavanserin 34 MG [Nuplazid] Sponsors:   Bjorn H. Ebdrup;   Rigshospitalet, Denmark;   GCP unit, Copenhagen University Hospital;   ACADIA Pharmaceuticals Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials